Position in ZTS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$5,415,081
+$1,360,280 QoQ
Shares Held
45,809
+42.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ALLSTATE CORP holds $15,014,275 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (36.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
45,809 | $5,415,081 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,710 | $2,792,935 | |
| 3 | VTRS |
Viatris Inc
|
153,602 | $2,075,163 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
12,349 | $1,626,857 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
60,074 | $1,437,570 | |
| 6 | ALKS |
Alkermes plc.
|
29,154 | $1,030,885 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
56,727 | $367,023 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
21,622 | $268,761 |
All Filings in ZTS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,415,081 | 45,809 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,054,801 | 32,227 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,287,713 | 15,635 | Shares | Sole | 2025-10-29 | |
| 2025-03-31 | $1,272,909 | 7,731 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,186,357 | 13,419 | Shares | Sole | 2025-02-12 | |
| 2024-06-30 | $262,467 | 1,514 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $270,059 | 1,596 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $315,002 | 1,596 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $370,751 | 2,131 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $366,979 | 2,131 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $354,350 | 2,129 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,867,397 | 19,566 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,798,016 | 12,125 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,088,807 | 12,152 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,298,534 | 12,188 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,221,161 | 37,787 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,343,658 | 12,072 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,372,735 | 12,732 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,097,318 | 13,318 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,333,053 | 14,097 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,376,036 | 14,368 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,115,486 | 15,437 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,046,864 | 17,392 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||